Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI tutor shows promise in teaching med students about hypertension

NCT ID NCT06776354

Knowledge-focused Sponsor: zhen wang Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether an AI teaching tool (GPT) helps medical students learn about high blood pressure better than traditional methods. Fifty-two students took part, either using the AI system or standard materials. The goal was to see if the AI improved test scores and how students felt about the learning experience.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

52 people

The number who actually took part.

Started

Oct 2024

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 30 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Graduate or regulatory trainee, currently rotating in cardiology and willing to participate in research. * Age between 18-30 years old, gender not limited. * No specialized training experience in hypertension diagnosis and treatment, only possessing basic medical theoretical knowledge. * Able to accept a 4-week teaching intervention (2 hours of study per week). * Sign the informed consent form and be aware of the research purpose and process. Exclusion Criteria: * Graduate students or trained interns who have received specialized training in hypertension medication treatment. * Students unable to complete the full course of study (e.g., rotations shorter than four weeks or potential mid-course withdrawal). * Unable to consistently participate in educational interventions (e.g., conflicts with study schedule). * Have severe physical or mental health issues that may affect the learning process. * Have language comprehension barriers or cognitive impairments, making it difficult to complete learning tasks.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GPT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GPT Hypertension Medical education

Contacts and locations

Locations

  • 678 Furong Road, Economic Development Zone, Hefei City, Anhui Province, China

    Hefei, Anhui, 230601, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.